Effects of Paclitaxel on Intimal Hyperplasia

• Status: Completed
• Trial end date: 2015-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a single, one time, limited dose infusion of Paclitaxel, that will potentially prevent recurrent stenosis secondary to intimal hyperplasia when compared to the control group at 10 months.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Patrick Kelly
• Treatments: Albumin-Bound Paclitaxel; Paclitaxel

Criteria

Inclusion Criteria:

• ability to provide informed consent

• age 18-90 years old

• Rutherford 1-6

• occlusion or stenosis in the infrainguinal vessels

Exclusion Criteria:

• inability to pass the guide wire across the lesion

• pregnant or lactating women

• specific limb has not been previously treated with endovascular intervention